USD 0.27
(5.14%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 33.59 Thousand USD | -3.26% |
2022 | 34.73 Thousand USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 69.67 Thousand USD | -9.34% |
2019 | 76.84 Thousand USD | -8.18% |
2018 | 83.69 Thousand USD | -48.82% |
2017 | 163.53 Thousand USD | 163.9% |
2016 | 61.96 Thousand USD | 47.83% |
2015 | 41.91 Thousand USD | 31.52% |
2014 | 31.87 Thousand USD | -5.28% |
2013 | 33.65 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | -100.0% |
2024 Q1 | 33.59 Thousand USD | 0.0% |
2023 Q3 | 33.59 Thousand USD | 0.0% |
2023 FY | 33.59 Thousand USD | -3.26% |
2023 Q2 | 33.59 Thousand USD | 0.0% |
2023 Q1 | 33.59 Thousand USD | -3.26% |
2023 Q4 | 33.59 Thousand USD | 0.0% |
2022 Q4 | 34.73 Thousand USD | -8.0% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 FY | 34.73 Thousand USD | 0.0% |
2022 Q3 | 37.75 Thousand USD | 0.0% |
2021 Q4 | - USD | -100.0% |
2021 FY | - USD | -100.0% |
2021 Q1 | 69.64 Thousand USD | -0.04% |
2021 Q3 | 69.64 Thousand USD | 0.0% |
2021 Q2 | 69.64 Thousand USD | 0.0% |
2020 Q1 | 76.74 Thousand USD | -0.14% |
2020 Q3 | 76.65 Thousand USD | -0.04% |
2020 Q4 | 69.67 Thousand USD | -9.11% |
2020 FY | 69.67 Thousand USD | -9.34% |
2020 Q2 | 76.68 Thousand USD | -0.07% |
2019 Q4 | 76.84 Thousand USD | -29.9% |
2019 Q3 | 109.62 Thousand USD | 9.84% |
2019 FY | 76.84 Thousand USD | -8.18% |
2019 Q2 | 99.8 Thousand USD | 19.25% |
2019 Q1 | 83.69 Thousand USD | 0.0% |
2018 Q1 | 157.53 Thousand USD | -3.67% |
2018 Q4 | 83.69 Thousand USD | -47.96% |
2018 Q2 | 157.31 Thousand USD | -0.14% |
2018 Q3 | 160.83 Thousand USD | 2.23% |
2018 FY | 83.69 Thousand USD | -48.82% |
2017 Q4 | 163.53 Thousand USD | 104.77% |
2017 Q2 | 89.52 Thousand USD | 44.3% |
2017 FY | 163.53 Thousand USD | 163.9% |
2017 Q1 | 62.03 Thousand USD | 0.11% |
2017 Q3 | 79.86 Thousand USD | -10.79% |
2016 FY | 61.96 Thousand USD | 47.83% |
2016 Q3 | 284.85 Thousand USD | -15.32% |
2016 Q4 | 61.96 Thousand USD | -78.25% |
2016 Q1 | 38.33 Thousand USD | -8.54% |
2016 Q2 | 336.4 Thousand USD | 777.5% |
2015 Q3 | 470.05 Thousand USD | 6.69% |
2015 Q1 | 453.03 Thousand USD | 1321.36% |
2015 Q2 | 440.58 Thousand USD | -2.75% |
2015 Q4 | 41.91 Thousand USD | -91.08% |
2015 FY | 41.91 Thousand USD | 31.52% |
2014 Q2 | 13.02 Thousand USD | 5.86% |
2014 Q4 | 31.87 Thousand USD | 149.46% |
2014 FY | 31.87 Thousand USD | -5.28% |
2014 Q1 | 12.3 Thousand USD | -63.42% |
2014 Q3 | 12.77 Thousand USD | -1.93% |
2013 Q4 | 33.65 Thousand USD | -20.6% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | 42.38 Thousand USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | 33.65 Thousand USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
American Medical Technologies Inc. | 133.82 Thousand USD | 74.895% |
Ansell Limited | 457.04 Million USD | 99.993% |
Ansell Limited | 457.9 Million USD | 99.993% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 43.33 Million USD | 99.922% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 27.89 Thousand USD | -20.466% |
Psykey, Inc. | 49.94 Thousand USD | 32.723% |
ConvaTec Group Plc | 395.54 Million USD | 99.992% |
ConvaTec Group Plc | 396.1 Million USD | 99.992% |
Encision Inc. | 1.4 Million USD | 97.604% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | -9294.00 USD | 461.502% |
LifePoint, Inc. | 2.3 Million USD | 98.545% |
Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 98.602% |
Paradigm Medical Industries, Inc. | 441 Thousand USD | 92.381% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 91.88 Thousand USD | 63.434% |
Reflect Scientific, Inc. | 972.29 Thousand USD | 96.544% |
SmileDirectClub, Inc. | 49.87 Million USD | 99.933% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.99% |
SheerVision, Inc. | 339.66 Thousand USD | 90.108% |
Vasamed, Inc. | 449.02 Thousand USD | 92.518% |
Wearable Health Solutions, Inc. | 8555.00 USD | -292.729% |
Yubo International Biotech Limited | 322.17 Thousand USD | 89.571% |